Literature DB >> 15066143

Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration.

Tom Schilling1, Christian Stock, Albrecht Schwab, Claudia Eder.   

Abstract

Abstract Migration of microglial cells towards damaged tissue plays a key role in central nervous system regeneration under pathological conditions. Using time lapse video microscopy we show that lysophosphatidic acid (LPA) enhances chemokinetic migration of murine microglial cells. In the presence of 1 micro m LPA, the mean migration rate of microglial cells was increased 3.8-fold. In patch-clamp studies we demonstrate that LPA induces activation of a Ca(2+)-activated K(+) current. Microglial Ca(2+)-activated K(+) currents were abolished by either 50 nm charybdotoxin or 10 micro m clotrimazole. In contrast, 5 micro m paxilline did not have any significant effects on Ca(2+)-activated K(+) currents. The LPA-stimulated migration of microglial cells was inhibited by blockers of IKCa1 Ca(2+)-activated K(+) channels. The mean migration rate of LPA-stimulated cells was decreased by 61% in the presence of 50 nm charybdotoxin or by 51% during exposure to 10 micro m clotrimazole. Microglial migration was not inhibited by 5 micro m paxilline. It is concluded that IKCa1 Ca(2+)-activated K(+) channels are required for LPA-stimulated migration of microglial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066143     DOI: 10.1111/j.1460-9568.2004.03265.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  58 in total

1.  The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.

Authors:  Yi-Je Chen; Girija Raman; Silke Bodendiek; Martha E O'Donnell; Heike Wulff
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-13       Impact factor: 6.200

2.  Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.

Authors:  Izumi Maezawa; Pavel I Zimin; Heike Wulff; Lee-Way Jin
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 3.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 4.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

Review 5.  Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia.

Authors:  Lucio Annunziato; Francesca Boscia; Giuseppe Pignataro
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-03       Impact factor: 6.200

6.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

7.  Large-conductance calcium-activated potassium channels mediate lipopolysaccharide-induced activation of murine microglia.

Authors:  Xiaoying Yang; Guiqin Wang; Ting Cao; Li Zhang; Yunzhi Ma; Shuhui Jiang; Xinchen Teng; Xiaohui Sun
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

8.  H-ras transformation sensitizes volume-activated anion channels and increases migratory activity of NIH3T3 fibroblasts.

Authors:  Linda Schneider; Thomas K Klausen; Christian Stock; Sabine Mally; Søren T Christensen; Stine Falsig Pedersen; Else K Hoffmann; Albrecht Schwab
Journal:  Pflugers Arch       Date:  2007-10-20       Impact factor: 3.657

Review 9.  Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain.

Authors:  P Pedarzani; M Stocker
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

10.  N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

Authors:  Douglas McHugh; Sherry S J Hu; Neta Rimmerman; Ana Juknat; Zvi Vogel; J Michael Walker; Heather B Bradshaw
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.